Changes in fibroblast growth factor 2 and its receptors in bovine follicles before and after GnRH application and after ovulation.
The aim of this study was to evaluate the expression pattern of fibroblast growth factor 2 (FGF2), its receptor variants (FGFR1IIIc, FGFR2IIIc) and nucleolin in time-defined follicle classes before and after GnRH application and after ovulation in the cow. Ovaries containing preovulatory follicles or new corpora lutea (CL) were collected at approximately 0, 4, 10, 20 and 25 h (follicles) and 60 h (new CL) relative to injection of GnRH to induce an LH surge (n = 5 animals per group). The expressions of FGF2 and FGFR1IIIc mRNA were significantly up-regulated only in the follicle group 4 h after GnRH (during the LH surge) with a significant down-regulation immediately afterwards. Western blot analyses showed two protein bands with at 22 and 18 kDa with apparent up-regulation beginning with the LH surge (4 h) and maximum levels 20 h after GnRH. FGF2 protein in follicles collected at 0 h (before LH surge) was localised in theca tissue (endothelial and pericytes of blood vessels) but not in granulosa cells (GCs). The FGF2 staining (by immunohistochemistry) pattern changed dramatically after the LH surge for a short period (about 2 days) and FGF2 protein was localised dominantly in the nucleus of many GCs, while most capillary endothelial cells were FGF2 immunonegative. In conclusion, the novel observation of FGF2 up-regulation and the distinct change in FGF2 localisation from theca (cytoplasm of endothelial cells) to the nucleus of GCs after the LH surge may be important for survival of GCs or for the transition of the GCs to luteal cells.
Berisha
Bajram
B
Physiology, Technical University of Munich, Weihenstephaner Berg 3, D-85350 Freising, Germany.
Steffl
Martin
M
Amselgruber
Werner
W
Schams
Dieter
D
D000818:Animals; D017209:Apoptosis; D015153:Blotting, Western / Q000379:methods; D002417:Cattle; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000032:analysis* / Q000235:genetics / Q000378:metabolism; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology*; D006107:Granulosa Cells / Q000502:physiology; D007150:Immunohistochemistry / Q000379:methods; D008184:Luteal Cells / Q000502:physiology; D006080:Ovarian Follicle / Q000378:metabolism*; D010060:Ovulation / Q000502:physiology*; D010062:Ovulation Induction; D010750:Phosphoproteins / Q000032:analysis / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D016601:RNA-Binding Proteins / Q000032:analysis / Q000378:metabolism; D051497:Receptor, Fibroblast Growth Factor, Type 2 / Q000032:analysis* / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D000097796:Nucleolin
D016222:Fibroblast Growth Factor 2; D007987:Gonadotropin-Releasing Hormone; D010750:Phosphoproteins; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; D051497:Receptor, Fibroblast Growth Factor, Type 2; D000097796:Nucleolin